I graduated as a medical doctor from Aarhus University in 2023. In 2019, I took a research year, where I used a special type of MRI scan (BOLD-MRI) to study how the drugs Empagliflozin and Semaglutide affect oxygen levels in the kidneys.
Since June 2026, I have been a PhD fellow. In my current project, I study how empagliflozin changes the way the heart and kidneys use ketones as fuel. The patients have type 2 diabetes and existing kidney and heart disease. I use two PET tracers, 11[C]-beta-hydroxybutyrate and 11[C]-acetate, to follow this process.
Designing and running a randomized, double-blind clinical trial that studies how the heart and kidneys metabolise ketones in people with type 2 diabetes who are treated with empagliflozin.
I am also running an animal study in pigs, where I examine how the PET tracer 11[C]-beta-hydroxybutyrate behaves in the kidneys.